Evaluation of amotosalem treated platelets over 7 days of storage with an automated cytometry assay panel

International Journal of Laboratory Hematology

Volumn 35, Issue 6, 2013, Pages 637-643

  Diquattro, M ^a   De Francisci, G ^b   Bonaccorso, R ^b   Tagliavia, A M ^a   Marcatti, M ^a   Palma, B ^a   Agliastro, R ^b  

^a Laboratory of Clinical Pathology ^*  (Italy)

^b ARNAS Civico   (Italy)

Author keywords

Flow cytometry; Laboratory automation; Platelet transfusion; Platelets

Indexed keywords

AMOTOSALEM; FIBRINOGEN RECEPTOR; LACTATE DEHYDROGENASE; MEMBRANE RECEPTOR; NONOXINOL 9; PSORALEN; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ABSORPTION; ANALYSIS OF VARIANCE; ARTICLE; BLOOD STORAGE; CLINICAL STUDY; CONTROLLED STUDY; DEVICES; DRUG EFFICACY; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY AUTOMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIGHT SCATTERING; OPTICAL DENSITY; PARAMETERS; PARTICLE SIZE; PATHOGEN INACTIVATION; PATHOGENESIS; PLATELET MICROPARTICLE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE TRANSFUSION; THROMBOCYTE VOLUME;

FLOW CYTOMETRY; LABORATORY AUTOMATION; PLATELET TRANSFUSION; PLATELETS;

BLOOD PLATELETS; BLOOD PRESERVATION; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTEGRIN BETA3; PHENOTYPE; PLATELET MEMBRANE GLYCOPROTEIN IIB; PSORALENS; TIME FACTORS;

EID: 84887817094     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12102     Document Type: Article

References (39)

1. Van Rhenen D, Gulliksson H, Cazenave J-P, Pamphilon D, Ljungman P, Klüter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003;101:2426-33.
2. McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Urphy S, Howard F 4th, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004;104:1534-41.
3. De Francisci G, Agliastro R, Bonaccorso R. Clinical trial of the use of Pathogen Inactivated Platelets, with Helinx Technology, in Cardio Paediatric Surgery and Cirrhotic patients. Transfusion 2004;44(Suppl.9S):17A.
4. Agliastro R, De Francisci G, Bonaccorso R. Clinical Study in Pediatric Hemato-Oncology Patients: Efficacy of Pathogen inactivated Buffy Coat Platelets Versus Aphaeresis Platelets. Transfusion 2006;46(Suppl.9S):117A.
5. Lozano M, Knutson F, Tardivel R, Cid J, Maymó RM, Lof H, Roddie H, Pelly J, Docherty A, Sherman C, Lin L, Propst M, Corash L, Prowse C. A multicentre study of therapeutic efficacy and safety of platelet components treated with amotosalem and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion. Br J Haematol 2011;153(Suppl.3):393-401.
6. Cazenave J-P, Abeil B, Wiesel ML, Laforêt M, Isola H. In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using Amotosalem. Vox Sang 2004;86:201-2.
7. Slichter SJ. Extension of Platelet Storage: Fact or Fantasy. Gaithersburg, MD: Food and Drug Administration Blood Products Advisory Committee Meeting, 2002.
8. Murphy S, Gardner FH. Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies. J Clin Invest 1971;50:370-7.
9. Zbigniew RM, Oleksowicz L, Dutcher JP, De Leon-Fernandez M, Lalezari P, Puszkin EG. A novel technique for preparing improved buffy coat platelet concentrates. Blood Cells Mol Dis 1995;21(Suppl.1):25-33.
10. Rock G, Freedman M, Hamilton C, Bormanis J. New methods showing in vitro changes of platelets. Transfus Apher Sci 2006;35:145-9.
11. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006;20:1-26.
12. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003;1:1655-62.
13. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50- to 100-fold higher specific pro-coagulant activity than activated platelets. Thromb Haemost 2007;97:425-34.
14. Kunz D, Kunz WS, Scott CS, Gressner AM. Automated CD61 immunoplatelet analysis of thrombocytopenic samples. Br J Haematol 2001;112:584-92.
15. Grimaldi E, del Vecchio L, Scopacasa F, Lo Pardo C, Capone F, Pariante S, Scalia G, De Caterina M. Evaluation of the platelet counting by Abbott CELL-DYN SAPPHIRE haematology analyser compared with flow cytometry. Int J Lab Hematol 2009;31:151-60.
16. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Diqnat-George FF. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? Thromb Haemost 2009;7(Suppl.1):190-7.
17. Roemer B, Scott C. Platelet microparticles (PMP): feasibility analysis of PMP quantitation using the Cell-Dyn Sapphire PLTFlow mode. Int J Lab Hematol 2008;30(Suppl.1):86.
18. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995;48:257-62.
19. Cardigan R, Turner C, Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 2005;88:153-63.
20. Wang C, Mody M, Herst R, Sher G, Freedman J. Flow cytometric analysis of platelet function in stored platelet concentrates. Transfus Sci 1999;20:129-39.
21. Hervig T, Haugen T, Liseth K, Kjeldsen-Kragh J, Scott CS, Johannessen B. The platelet count accuracy of platelet concentrates obtained by using automated analysis is influenced by instrument bias and activated platelet components. Vox Sang 2004;87:196-203.
22. Johannessen B, Haugen T, Scott CS. Standardisation of platelet counting accuracy in blood banks by reference to an automated immunoplatelet procedure: comparative evaluation of Cell-Dyn CD4000 impedance and optical platelet counts. Transfus Apher Sci 2001;25:93-106.
23. Devine DV, Bradley AJ, Maurer E, Levin E, Chahal S, Serrano K, Gyongyossy-Issa MI. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999;39:724-34.
24. Apelseth TØ, Bruserud Ø, Wentzel-Larsen T, Bakken AM, Bjørsvik S, Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single- donor platelet concentrates during long-term storage. Transfusion 2007;47:653-65.
25. Apelseth TO, Hervig T. In vitro evaluation of platelet concentrates during storage: platelet counts and markers of platelet destruction. Transfus Apher Sci 2007;37:261-8.
26. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience 2004-2006. Transfusion 2007;47:1134-42.
27. Ramírez AS, Jenkins C, Dion J, Bernier F, Delage G, Goldman M. Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007;47:421-9.
28. Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman P, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S, Corash L. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997;37:423-35.
29. Lin L, Dikeman R, Molini B, Ukehart SA, Lane R, Dupuis K, Metzel P, Corash L. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004;44:1496-504.
30. Solheim BG. Pathogen reduction of blood components. Transfus Apher Sci 2008;39:75-82.
31. Owens M, Holme S, Heaton A, Sawyer S, Cardinali S. Post-transfusion recovery of function of 5-day stored platelet concentrates. Br J Haematol 1992;80:539-44.
32. Dumont LJ, AuBuchon JP, Whitley P, Herschel LH, Johson A, McNeil D, Sawyer S, Roger JC. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002;42:847-54.
33. Cardigan R, Williamson LM. The quality of platelets after storage for 7 days. Transfus Med (Oxford) 2003;13:173-87.
34. Rock G, Neurath D, Cober N, Freedman M, Leduc M, Nelson E, Lu M. Seven-day storage of random donor PLT concentrates. Transfusion 2003;43:1374-7.
35. Dijkstra-Tiekstra MJ, Pietersz RNI, Hendriks EC, Reesink HW, Huijgens PC. In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days. Transfusion 2004;44:330-6.
36. Slichter SJ, Bolgiano D, Jones MK, Christoffel T, Corson J, Rose L, Foley J, Popovski M, Baril LL, Corda T, Dincecco DM, Snyder EL. Viability and function of 8-day-stored apheresis platelets. Transfusion 2006;46:1763-9.
37. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vitro tracking of platelets circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A, 1996;93(Suppl.21):11877-82.
38. Rinder HM, Snyder EL, Tracey JB, Dincecco D, Wang C, Baril L, Rinder CS, Smith BR. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 2003;43(Suppl.9):1230-7.
39. Mintz PD, Anderson G, Avery N, Clark P, Bonner Rf. Assessment of the correlation of platelet morphology with in vivo recovery and survival. Transfusion 2005;45(Suppl.2):72S-80S.